Hanmi Science Co Ltd
KRX:008930
Hanmi Science Co Ltd
Operating Income
Hanmi Science Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Hanmi Science Co Ltd
KRX:008930
|
Operating Income
₩56B
|
CAGR 3-Years
28%
|
CAGR 5-Years
49%
|
CAGR 10-Years
13%
|
|
Yuhan Corp
KRX:000100
|
Operating Income
₩34.7B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-6%
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Operating Income
-₩37.5B
|
CAGR 3-Years
46%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Operating Income
₩220.7B
|
CAGR 3-Years
65%
|
CAGR 5-Years
21%
|
CAGR 10-Years
14%
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Operating Income
₩8.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-7%
|
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
Operating Income
₩27.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
47%
|
CAGR 10-Years
16%
|
See Also
What is Hanmi Science Co Ltd's Operating Income?
Operating Income
56B
KRW
Based on the financial report for Mar 31, 2024, Hanmi Science Co Ltd's Operating Income amounts to 56B KRW.
What is Hanmi Science Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
13%
Over the last year, the Operating Income growth was 78%. The average annual Operating Income growth rates for Hanmi Science Co Ltd have been 28% over the past three years , 49% over the past five years , and 13% over the past ten years .